Antidepressant studies in Parkinson's disease: A review and meta‐analysis

Weintraub, Daniel, Morales, Knashawn H., Moberg, Paul J., Bilker, Warren B., Balderston, Catherine, Duda, John E., Katz, Ira R., Stern, Matthew B.·2005·Movement Disorders
DOI 10.1002/mds.20555

Cited by (190)

Items 101–190 of 190

  1. Non-invasive brain stimulation for treating psychiatric symptoms in Parkinson’s disease: A systematic review and meta-analysis
    Haibo Zheng, Bing Liu, Jing Shen, Feng Xie, Qiu-Ming Ji, Xinyue Zhu · 2022 · Journal of Clinical Neuroscience
  2. Treatment of Early Parkinson’s Disease
    Tanya Simuni, Kelly E. Lyons, Rajesh Pahwa, Robert A. Hauser, Cynthia L. Comella, Lawrence W. Elmer, Daniel A. Weintraub · 2009 · European Neurology
  3. Coaxil (tianeptine) in the treatment of depression in Parkinson’s disease
    Oleg Semenovich Levin · 2007 · Neuroscience and Behavioral Physiology
  4. Anhedonia in Japanese patients with Parkinson's disease
    S Fujiwara, Fumiharu Kimura, Takafumi Hosokawa, Shimon Ishida, Masakazu Sugino, Toshiaki Hanafusa · 2011 · Geriatrics and gerontology international/Geriatrics & gerontology international
  5. Treatment of dementia associated with Parkinson's disease
    Murat Emre · 2007 · Parkinsonism & Related Disorders
  6. Epidemiology of major depression in Belgian parkinsonian patients.
    Jean-Émile Vanderheyden, Michel Gonce, Philip Bourgeois, Patrick P Cras, A. R. De Nayer, Anja Flamez, Frédéric Supiot, Anne‐Françoise Donneau, Adelin Albert, Valérie Berlaimont · 2010 · PubMed
  7. Recognition and treatment of neuropsychiatric disturbances in Parkinson’s disease
    Umer Akbar, Joseph H. Friedman · 2015 · Expert Review of Neurotherapeutics
  8. Management of the behavioral aspects of Parkinson’s disease
    Leora L. Borek, Kelvin L. Chou, Joseph H. Friedman · 2007 · Expert Review of Neurotherapeutics
  9. Management of Depression in Parkinson’s Disease
    Anna Frenklach · 2016 · American Journal of Psychiatry Residents Journal
  10. Clozapine or Haloperidol in rats prenatally exposed to methylazoxymethanol, a compound inducing entorhinal-hippocampal deficits, alter brain and blood neurotrophins' concentrations.
    Marco Fiore, Veronica Di Fausto, Angela Iannitelli, Luigi Aloe · 2008 · PubMed
  11. Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review
    Matteo E.M. Vismara, Beatrice Benatti, Gregorio Nicolini, Ilaria Cova, Edoardo Monfrini, Alessio Di Fonzo, Vincenza Fetoni, Caterina Adele Viganò, Alberto Priori, Bernardo Maria Dell’Osso · 2022 · BMC Neurology
  12. Role of the Central Cholinergic Nervous System in Motor and Non-Motor Symptoms of Parkinson’s Disease
    Si-Yuan Tian, Xin Cao, Guo-Jin Liu, Ying Zi, Hui‐Xian Zhu, Yi‐Miao Jiang, Wei-Wei Lou, Xiaoxia Fang, Ling Shan, Zhan Liu et al. · 2025 · Current Neuropharmacology
  13. Treatment of depression in Parkinson’s disease
    Matthew A. Menza, Roseanne D. Dobkin, Humberto Marín · 2006 · Current Psychiatry Reports
  14. Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics
    Ankur Butala, Melissa D. Shepard, Gregory M. Pontone · 2019 · Handbook of clinical neurology
  15. Distant delivery of a mindfulness-based intervention for people with Parkinson's disease: The study protocol of a randomised pilot trial
    Bogosian, A., Hurt, C. S., Vasconcelos e Sa, D., Hindle, J. V., McCracken, L., Cubi-Molla, P. · 2017 · Pilot and Feasibility Studies
  16. Prioritising target non-pharmacological interventions for research in Parkinson’s disease: achieving consensus from key stakeholders
    Angeliki Bogosian, Lorna Rixon, Catherine S. Hurt · 2020 · Research Involvement and Engagement
  17. The Role of Telemedicine in the Treatment of Cognitive and Psychological Disorders in Parkinson’s Disease: An Overview
    Dèsiréè Latella, Giuseppa Maresca, Caterina Formica, Chiara Sorbera, Amelia Bringandì, Giuseppe Di Lorenzo, Angelo Quartarone, Silvia Marino · 2023 · Brain Sciences
  18. Depression in Parkinson's disease.
    Zoltán Rihmer, Xénia Gonda, Péter Döme · 2014 · PubMed
  19. The multimodal effect of circadian interventions in Parkinson's disease: A narrative review
    Katarzyna Śmiłowska, Daniel J. van Wamelen, Bastiaan R. Bloem · 2023 · Parkinsonism & Related Disorders
  20. Nondopaminergic Treatments for Parkinson’s Disease
    Philippe Huot, Susan Helen Fox · 2011 · Neurodegenerative Disease Management
  21. High-frequency repetitive transcranial magnetic stimulation to the left dorsolateral prefrontal cortex of patients with Parkinson’s disease and treatment-resistant depression: a pilot study
    René Randver, Külli Davel, Toomas Toomsoo · 2019 · Neurocase
  22. The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease
    Charidimou, Andreas, Seamons, John, Selai, Caroline, Schrag, Anette · 2011 · Parkinson's Disease
  23. Development of a Simple Electrochemical Sensor for Antipsychotic Medication Perphenazine Based on Mn3O4 Nanomaterial Modified Glassy Carbon Electrode
    Prajakta R. Kamble, Manish Singh Sengar, Priya Kumari, Arun K Kadu · 2025 · Journal of The Electrochemical Society
  24. Psychiatric Issues in Parkinson's Disease
    Daniel A. Weintraub · 2009 · Blue books of neurology
  25. Psychische Störungen bei somatischen Krankheiten
    H.P. Kapfhammer · 2011 · Springer eBooks
  26. Disorders of mood and affect in Parkinson's disease
    Daniel A. Weintraub, Matthew B. Stern · 2007 · Handbook of clinical neurology
  27. Depression in Parkinson's disease
    Marina Romanovna Nodel, Marina Romanovna Nodel · 2010 · Neurology neuropsychiatry Psychosomatics
  28. Cognitive and Psychiatric Disturbances in Parkinson’s Disease
    Dag Aarsland, Uwe Ehrt, Irena Rektorová · 2011 · Aging Health
  29. Troubles psychiques et comportementaux et leurs traitements
    Gilles Fénelon · 2011 · Elsevier eBooks
  30. Glad about SAD (PD)
    Joseph H. Friedman, Daniel A. Weintraub · 2012 · Neurology
  31. What can we expect from the serotonergic side of l-DOPA?
    Philippe De Deurwaerdère, Sylvia Navailles · 2012 · Revue Neurologique
  32. What is a rational antidepressant treatment for major depression in patients with Parkinson's disease?
    Minako Hagikura, Kunihiro Iwamoto, Branko Aleksić, Norio Ozaki · 2012 · Psychiatry and Clinical Neurosciences
  33. Intervening in the neuropsychiatric features of Parkinson’s disease
    Daniel A. Weintraub, Matthew B. Stern · 2007 · Expert Review of Neurotherapeutics
  34. The Use of Melatoninergic Antidepressants for Stabilization of Remission in Depression Comorbid with Alcohol Abuse, Anxiety or Neuropsychiatric Disorders: A Systematic Review
    Климанова Светлана Георгиевна, D. S. Radionov, Шова Наталья Игоревна, Yuliia V. Kotsyubinskaya, Yuliia V. Yarygina, Березина Анна Андреевна, Н. А. Сивакова, Старунская Диана Андреевна, O. N. Yakunina, A. E. Andrianova et al. · 2024 · Consortium Psychiatricum
  35. Neuropsychology of Movement Disorders and Motor Neuron Disease
    Alexander I. Tröster, Steven Paul Woods · 2010 · Springer eBooks
  36. Treatment Strategies and Quality-of-Care Indicators for Patients With Parkinson's Disease
    Jack J. Chen, Mark Lew, Andrew D. Siderowf · 2009 · Journal of Managed Care Pharmacy
  37. Symptoms of Parkinson's Disease
    Abdul Qayyum Rana · 2011 · InTech eBooks
  38. Update in Parkinson’s Disease
    Ftima Carrillo, Pablo Mir · 2012 · InTech eBooks
  39. Neuropsychological Issues in Deep Brain Stimulation of Neurological and Psychiatric Disorders
    Alexander I. Tröster, April B. McTaggart, Ines Ann Heber · 2008 · Humana Press eBooks
  40. Established therapies and novel targets in the treatment of Parkinson’s disease
    Lívia Dézsi, László Vécsei · 2009 · Expert Review of Clinical Pharmacology
  41. Depression in Parkinson’s Disease: An Update
    Jeana L. Benton, Steven P. Wengel, W. J. Burke · 2012 · Humana Press eBooks
  42. Importância das manifestações não motoras da Doença de Parkinson
    Egberto Reis Barbosa, Luciano Magalhães Melo · 2019 · Revista Neurociências
  43. Cuadro confusional y alucinaciones por interacción entre rasagilina y escitalopram
    Ana Cristina Bandrés Liso, Carla Toyas Miazza · 2009 · Farmacia Hospitalaria
  44. Pathophysiology of Non-Dopaminergic Monoamine Systems in Parkinson's Disease: Implications for Mood Dysfunction
    Nirmal Bhide, Christopher Bishop · 2011 · InTech eBooks
  45. Management of Nonmotor Symptoms of Parkinson's Disease
    Néstor Gálvez-Jiménez, Hubert H. Fernandez, Alberto Javier Espay, Susan Helen Fox · 2016 · Cambridge University Press eBooks
  46. Neuropsychology of Movement Disorders and Motor Neuron Disease: Parkinson’s Disease, Progressive Supranuclear Palsy, Essential Tremor, Huntington’s Disease, and Amyotrophic Lateral Sclerosis
    Alexander I. Tröster, Sarah J. Pulaski, Steven Paul Woods · 2019 · Springer eBooks
  47. Parkinson’s Disease Dementia
    Başar Bılgıç, Hasmet Ayhan Hanagasi, Murat Emre · 2014 · Neuropsychiatric symptoms of neurological disease
  48. Dépression et maladie de Parkinson
    Umberto Spampinato, François Tison · 2012 · Encyclopédie médico-chirurgicale. Neurologie
  49. Behavior and Personality Disturbances
    Carissa R. Gehl, Jane S. Paulsen · 2008 · Elsevier eBooks
  50. Depressive Disorders in the Elderly: A Review
    Edmond Chiu, David J. Ames, Brian Draper, John A Snowdon · 2009 · Wiley eBooks
  51. Trastornos de movimientos involuntarios
    David Myland Kaufman · 2008 · Elsevier eBooks
  52. Understanding and managing parkinsonism in patients with glucocerebrosidase mutations
    Jenny Kim, Ellen Sidransky, Grisel J. Lopez · 2015 · Expert Opinion on Orphan Drugs
  53. Parkinson Disease: Phenomenology and Treatment of the Most Common Psychiatric Symptoms
    Leora L. Borek · 2008
  54. Antidepressiva zur Behandlung der Depression bei Palliativpatienten: Eine systematische Literaturübersicht
    Mariam Ujeyl, Bruno Müller-Oerlinghausen · 2012 · Der Schmerz
  55. Mood Disorders in Parkinson’s Disease
    Po‐Heng Tsai, Ganesh Gopalakrishna · 2022 · Cambridge University Press eBooks
  56. Neuropsychiatric symptoms
    Per Odin, Kerstin Dietrich · 2011
  57. Troubles psychiques et comportementaux et leurs traitements
    Gabriel Robert, Gilles Fénelon · 2015 · Elsevier eBooks
  58. Alucinaciones secundarias a tratamiento en paciente con Parkinson
    Juan María Rubio López · 2023 · Revista Clínica de Medicina de Familia
  59. Clinical Disease Progression in Parkinson’s Disease
    Guido Werner Alves · 2006
  60. Troubles psychiques et comportementaux de la maladie de Parkinson
    Gilles Fénelon, Pierre Césaro · 2010 · Bulletin de l Académie Nationale de Médecine
  61. Troubles psychiques et comportementaux
    Gilles Fénelon, Jean‐Luc Houéto, Gabriel Robert · 2020 · Elsevier eBooks
  62. Depression and Parkinsonism
    Laura Marsh · 2010 · Elsevier eBooks
  63. Anxiety Syndromes and Panic Attacks
    Daniel A. Weintraub, Staci Hoops · 2011 · Parkinson s Disease
  64. Benchmarking in der Patientenversorgung
    Astrid Althaus, T. Kanis, Annika E. Spottke, Karla Maria Eggert, Inga Liepelt, Daniela Berg, F. Schneider, Richard C. Dodel · 2007 · Nervenheilkunde
  65. The impact of depression on life for people with Parkinson's disease
    Susan Mayor · 2007 · British Journal of Neuroscience Nursing
  66. Laser Literature Watch
    2006 · Photomedicine and Laser Surgery
  67. Cognitive Roles of Anterior and Posterior Pedunculopontine Tegmentum Subregions
    Jordan C Robinson · 2013 · Scholarship@Western (Western University)
  68. Depression in Parkinson's disease
    Uwe Ehrt · 2010 · NORA - Norwegian Open Research Archives
  69. Cognitive and Psychiatric Aspects of Parkinson’s Disease
    Caspar Stephani · 2011 · InTech eBooks
  70. Relevante Studien zur ParkinsonTherapie 2009-2010
    Andrés Ceballos-Baumann · 2010 · Nervenheilkunde
  71. Overview of Rating Scales in Old Age Psychiatry
    Kenneth Wilson, Ben Green, Pat Mottram · 2010
  72. Mood Disorders in Parkinson's Disease
    John Vincent Hindle · 2010
  73. Psychotropes et comorbidité somatique
    Bruno Millet, Jean‐Marie Vanelle, Joseph Benyaya · 2014 · Elsevier eBooks
  74. Antidepresivos
    FJ Arranz Estévez, José Ramón Doménech Bisén · 2011 · Elsevier eBooks
  75. Depressie bij de ziekte van Parkinson; de huidige stand van zaken
    Monique H.M. Timmer, Indira Tendolkar, Rianne A.J. Esselink · 2014 · Tijdschrift voor Neuropsychiatrie en Gedragsneurologie
  76. Depressione e malattia di Parkinson
    Umberto Spampinato, François Tison · 2013 · EMC - Neurologia
  77. Treatment of depression and anxiety in Parkinson’s Disease
    Lakkhina Troeung · 2013 · eSpace (Curtin University)
  78. A COMPARISON OF THREE DEPRESSION SCALES AS
    Sarah F. Baillon · 2013
  79. Management of disease-related behavioral disturbances in Parkinson's disease
    Joseph H. Friedman · 2016 · Cambridge University Press eBooks
  80. Lessons and challenges of trials for cognitive and behavioral complications of Parkinson's disease
    Daniel A. Weintraub, Lama M. Chahine · 2016 · Cambridge University Press eBooks
  81. Clinical Trials in Parkinson's Diease: Lessons, Controversies and Challenges
    2016 · Cambridge University Press eBooks
  82. Treatment of Dementia Associated with Parkinson's Disease
    Murat Emre · 2011 · Parkinson s Disease
  83. Psychotropes et comorbidité somatique
    Bruno Millet, Jean‐Marie Vanelle, Joseph Benyaya · 2010 · Elsevier eBooks
  84. Current awareness in human psychopharmacology
    2006 · Human Psychopharmacology Clinical and Experimental
  85. Current awareness in geriatric psychiatry
    John Wiley & Sons, Ltd. · 2006 · International Journal of Geriatric Psychiatry
  86. Neuropsychology
    Kevin M. Duff, Jane S. Paulsen · 2008 · Elsevier eBooks
  87. Late (Complicated) Parkinson's Disease
    Martin W.I.M. Horstink, E. Tolosa, Ubaldo Bonuccelli, Günther Deuschl, A. Friedman, Petr Kaňovský, J.P. Larsen, Andrew J. Lees, W. Oertel, Werner H Poewe et al. · 2006 · Wiley eBooks
  88. Transcranial magnetic stimulation and SSRIs in the complex treatment of Parkinson’s disease patients with depressive disorders
    Federal State Budgetary Educational Institution of Higher Education ", А. O. Prosvetov, of the Ministry of Health of the Russian Federation, Boris Dmitrievich Tsygankov, S. R. Rangus, E V Kuznetsov · 2023 · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery)
  89. Troubles psychiques et comportementaux
    Jean‐Luc Houéto, Ana Marquès · 2025 · Elsevier eBooks
  90. Comparative characteristics of depressive disorders in patients with multiple sclerosis
    Boris Dmitrievich Tsygankov, N. V. Zarubina, T. E. Evdokimova · 2026 · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery)